FAP and neoplasm: Since tumor stroma is one of the major obstacles that limit the penetration of the CAR T cells to the tumor site, scientists thought to engineer CAR T cells against the fibroblast-associated protein (FAP), which is highly expressed by tumor-associated fibroblasts.